Article Versions Notes

Fernández A, Navarro-Zapata A, Escudero A, Matamala N, Ruz-Caracuel B, Mirones I, Pernas A, Cobo M, Casado G, Lanzarot D, et al. Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy. Cancers. 2021; 13(3):577. https://doi.org/10.3390/cancers13030577

Fernández, Adrián, Alfonso Navarro-Zapata, Adela Escudero, Nerea Matamala, Beatriz Ruz-Caracuel, Isabel Mirones, Alicia Pernas, Marta Cobo, Gema Casado, Diego Lanzarot, and et al. 2021. "Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy" Cancers 13, no. 3: 577. https://doi.org/10.3390/cancers13030577

Fernández, A., Navarro-Zapata, A., Escudero, A., Matamala, N., Ruz-Caracuel, B., Mirones, I., Pernas, A., Cobo, M., Casado, G., Lanzarot, D., Rodríguez-Antolín, C., Vela, M., Ferreras, C., Mestre, C., Viejo, A., Leivas, A., Martínez, J., Fernández, L., & Pérez-Martínez, A. (2021). Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy. Cancers, 13(3), 577. https://doi.org/10.3390/cancers13030577